{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T21:27:13Z","timestamp":1790803633503,"version":"4.1.0"},"reference-count":56,"publisher":"Oxford University Press (OUP)","issue":"9","license":[{"start":{"date-parts":[[2023,6,28]],"date-time":"2023-06-28T00:00:00Z","timestamp":1687910400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/pages\/standard-publication-reuse-rights"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2023,9,5]]},"abstract":"Abstract<\/jats:title>\n \n STUDY QUESTION<\/jats:title>\n Should we perform oocyte accumulation to preserve fertility in women with Turner syndrome (TS)?<\/jats:p>\n <\/jats:sec>\n \n SUMMARY ANSWER<\/jats:title>\n The oocyte cryopreservation strategy is not well adapted for all TS women as their combination of high basal FSH with low basal AMH and low percentage of 46,XX cells in the karyotype significantly reduces the chances of freezing sufficient mature oocytes for fertility preservation.<\/jats:p>\n <\/jats:sec>\n \n WHAT IS KNOWN ALREADY<\/jats:title>\n An oocyte cryopreservation strategy requiring numerous stimulation cycles is needed to preserve fertility in TS women, to compensate for the low ovarian response, the possible oocyte genetic alterations, the reduced endometrial receptivity, and the increased rate of miscarriage, observed in this specific population. The validation of reliable predictive biomarkers of ovarian response to hormonal stimulation in TS patients is necessary to help practitioners and patients choose the best-personalized fertility preservation strategy.<\/jats:p>\n <\/jats:sec>\n \n STUDY DESIGN, SIZE, DURATION<\/jats:title>\n A retrospective bicentric study was performed from 1 January 2011 to 1 January 2023. Clinical and biological data from all TS women who have received from ovarian stimulation for fertility preservation were collected. A systematic review of the current literature on oocyte retrieval outcomes after ovarian stimulation in TS women was also performed (PROSPERO registration number: CRD42022362352).<\/jats:p>\n <\/jats:sec>\n \n PARTICIPANTS\/MATERIALS, SETTING, METHODS<\/jats:title>\n A total of 14 TS women who had undergone ovarian stimulation for fertility preservation were included, representing the largest cohort of TS patients published to date (n\u2009=\u200914 patients, 24 cycles). The systematic review of the literature identified 34 additional TS patients with 47 oocyte retrieval outcomes after ovarian stimulation in 14 publications (n\u2009=\u200948 patients, n\u2009=\u200971 cycles in total).<\/jats:p>\n <\/jats:sec>\n \n MAIN RESULTS AND THE ROLE OF CHANCE<\/jats:title>\n The number of cryopreserved mature oocytes on the first cycle for TS patients was low (4.0\u2009\u00b1\u20093.7). Oocyte accumulation was systematically proposed to increase fertility potential and was accepted by 50% (7\/14) of patients (2.4\u2009\u00b1\u20090.5 cycles), leading to an improved total number of 10.9\u2009\u00b1\u20097.2 cryopreserved mature oocytes per patient. In the group who refused the oocyte accumulation strategy, only one patient exceeded the threshold of 10 mature cryopreserved oocytes. In contrast, 57.1% (4\/7) and 42.9% (3\/7) of patients who have underwent the oocyte accumulation strategy reached the threshold of 10 and 15 mature cryopreserved oocytes, respectively (OR = 8 (0.6; 107.0), P\u2009=\u20090.12; OR= 11 (0.5; 282.1), P\u2009=\u20090.13). By analyzing all the data published to date and combining it with our data (n\u2009=\u200948 patients, n\u2009=\u200971 cycles), low basal FSH and high AMH concentrations as well as a higher percentage of 46,XX cells in the karyotype were significantly associated with a higher number of cryopreserved oocytes after the first cycle. Moreover, the combination of low basal FSH concentration (&lt;5.9\u2009IU\/l), high AMH concentration (&gt;1.13\u2009ng\/ml), and the presence of 46,XX cells (&gt;1%) was significantly predictive of obtaining at least six cryopreserved oocytes in the first cycle, representing objective criteria for identifying patients with real chances of preserving an adequate fertility potential by oocyte cryopreservation.<\/jats:p>\n <\/jats:sec>\n \n LIMITATIONS, REASONS FOR CAUTION<\/jats:title>\n Our results should be analyzed with caution, as the optimal oocyte number needed for successful live birth in TS patients is still unknown due to the low number of reports their oocyte use in the literature to date.<\/jats:p>\n <\/jats:sec>\n \n WIDER IMPLICATIONS OF THE FINDINGS<\/jats:title>\n TS patients should benefit from relevant clinical evaluation, genetic counseling and psychological support to make an informed choice regarding their fertility preservation technique, as numerous stimulation cycles would be necessary to preserve a high number of oocytes.<\/jats:p>\n <\/jats:sec>\n \n STUDY FUNDING\/COMPETING INTEREST(S)<\/jats:title>\n This research received no external funding. The authors declare no conflict of interest.<\/jats:p>\n <\/jats:sec>\n \n TRIAL REGISTRATION NUMBER<\/jats:title>\n N\/A.<\/jats:p>\n <\/jats:sec>","DOI":"10.1093\/humrep\/dead135","type":"journal-article","created":{"date-parts":[[2023,6,15]],"date-time":"2023-06-15T15:23:47Z","timestamp":1686842627000},"page":"1733-1745","source":"Crossref","is-referenced-by-count":15,"title":["Should we perform oocyte accumulation to preserve fertility in women with Turner syndrome? A multicenter study and systematic review of the literature"],"prefix":"10.1093","volume":"38","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-3354-1551","authenticated-orcid":false,"given":"S","family":"Brouillet","sequence":"first","affiliation":[{"name":"Department of Reproductive Biology-CECOS, CHU and University of Montpellier , Montpellier, France"},{"name":"Univ Montpellier, DEFE, INSERM 1203, Embryo Development Fertility Environment , Montpellier, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1956-8571","authenticated-orcid":false,"given":"N","family":"Ranisavljevic","sequence":"additional","affiliation":[{"name":"Department of Reproductive Medicine, CHU and University of Montpellier , Montpellier, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0875-1592","authenticated-orcid":false,"given":"C","family":"Sonigo","sequence":"additional","affiliation":[{"name":"Department of Reproductive Medicine and Fertility Preservation, Universit\u00e9 Paris Saclay, Assistance Publique H\u00f4pitaux de Paris, Antoine Beclere Hospital , Clamart, France"},{"name":"Universit\u00e9 Paris Saclay, INSERM, Physiologie et Physiopathologie Endocrinienne , Le Kremlin-Bic\u00eatre, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"E","family":"Haquet","sequence":"additional","affiliation":[{"name":"Department of Medical Genetics, CHU and University of Montpellier , Montpellier, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S","family":"Bringer-Deutsch","sequence":"additional","affiliation":[{"name":"Department of Reproductive Medicine, CHU and University of Montpellier , Montpellier, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"V","family":"Loup-Cabaniols","sequence":"additional","affiliation":[{"name":"Department of Reproductive Biology-CECOS, CHU and University of Montpellier , Montpellier, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S","family":"Hamamah","sequence":"additional","affiliation":[{"name":"Department of Reproductive Biology-CECOS, CHU and University of Montpellier , Montpellier, France"},{"name":"Univ Montpellier, DEFE, INSERM 1203, Embryo Development Fertility Environment , Montpellier, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M","family":"Willems","sequence":"additional","affiliation":[{"name":"Department of Medical Genetics, CHU and University of Montpellier , Montpellier, France"},{"name":"Institute for Neurosciences of Montpellier, U1298, Univ Montpellier, INSERM , Montpellier, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"T","family":"Anahory","sequence":"additional","affiliation":[{"name":"Department of Reproductive Medicine, CHU and University of Montpellier , Montpellier, France"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2023,6,28]]},"reference":[{"key":"2023090508450996800_dead135-B1","doi-asserted-by":"crossref","first-page":"16","DOI":"10.3390\/jdb10020016","article-title":"The hypothesis of the prolonged cell cycle in Turner syndrome","volume":"10","author":"Alvarez-Nava","year":"2022","journal-title":"J Dev Biol"},{"key":"2023090508450996800_dead135-B2","doi-asserted-by":"crossref","first-page":"374","DOI":"10.1016\/j.fertnstert.2020.03.009","article-title":"Bypassing physiological puberty, a novel procedure of oocyte cryopreservation at age 7: a case report and review of the literature","volume":"114","author":"Azem","year":"2020","journal-title":"Fertil Steril"},{"key":"2023090508450996800_dead135-B3","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1111\/j.1471-0528.2009.02423.x","article-title":"Conservation of fertility and oocyte genetics in a young woman with mosaic Turner syndrome","volume":"117","author":"Balen","year":"2010","journal-title":"BJOG"},{"key":"2023090508450996800_dead135-B4","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1002\/ajmg.c.31805","article-title":"The epidemiology of sex chromosome abnormalities","volume":"184","author":"Berglund","year":"2020","journal-title":"Am J Med Genet C Semin Med Genet"},{"key":"2023090508450996800_dead135-B5","doi-asserted-by":"crossref","first-page":"782","DOI":"10.1093\/humrep\/dew012","article-title":"Spontaneous fertility and pregnancy outcomes amongst 480 women with Turner syndrome","volume":"31","author":"Bernard","year":"2016","journal-title":"Hum Reprod"},{"key":"2023090508450996800_dead135-B6","doi-asserted-by":"crossref","first-page":"1104","DOI":"10.1016\/S0015-0282(16)57968-0","article-title":"Exaggerated effects of progestogen on uterine artery pulsatility index in Turner's syndrome patients receiving hormone replacement therapy","volume":"64","author":"Biljan","year":"1995","journal-title":"Fertil Steril"},{"key":"2023090508450996800_dead135-B7","doi-asserted-by":"crossref","first-page":"1489","DOI":"10.1016\/j.fertnstert.2008.07.1762","article-title":"Poor outcome in oocyte donation after elective transfer of a single cleavage-stage embryo in Turner syndrome patients","volume":"91","author":"Bodri","year":"2009","journal-title":"Fertil Steril"},{"key":"2023090508450996800_dead135-B8","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1016\/j.fertnstert.2018.12.009","article-title":"Oocyte quantity and quality are crucial for a perspective of fertility preservation in women with Turner syndrome","volume":"111","author":"Borini","year":"2019","journal-title":"Fertil Steril"},{"key":"2023090508450996800_dead135-B9","article-title":"Cryopreservation of oocytes retrieved from ovarian tissue to optimize fertility preservation in prepubertal girls and women","volume":"164","author":"Brouillet","year":"2020","journal-title":"J Vis Exp"},{"key":"2023090508450996800_dead135-B10","doi-asserted-by":"crossref","first-page":"2507","DOI":"10.1016\/j.fertnstert.2010.12.039","article-title":"Pregnancy rate and outcome in Swedish women with Turner syndrome","volume":"95","author":"Bryman","year":"2011","journal-title":"Fertil Steril"},{"key":"2023090508450996800_dead135-B11","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1016\/j.fertnstert.2020.03.002","article-title":"Fertility issues and pregnancy outcomes in Turner syndrome","volume":"114","author":"Calanchini","year":"2020","journal-title":"Fertil Steril"},{"key":"2023090508450996800_dead135-B12","doi-asserted-by":"crossref","first-page":"755","DOI":"10.1016\/j.fertnstert.2015.11.027","article-title":"Oocyte vitrification as an efficient option for elective fertility preservation","volume":"105","author":"Cobo","year":"2016","journal-title":"Fertil Steril"},{"key":"2023090508450996800_dead135-B13","doi-asserted-by":"crossref","first-page":"937","DOI":"10.1016\/S0015-0282(99)00378-7","article-title":"21-hydroxylase deficiency and Turner's syndrome: a reason for diminished endometrial receptivity","volume":"72","author":"Cohen","year":"1999","journal-title":"Fertil Steril"},{"key":"2023090508450996800_dead135-B1300","article-title":"Pregnancy in a woman with Turner mosaicism following ovarian stimulation and in vitro fertilization","volume":"13","year":"1996","journal-title":"J Assist Reprod Genet"},{"key":"2023090508450996800_dead135-B15","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1111\/j.1471-0528.2009.02422.x","article-title":"Oocyte cryopreservation after controlled ovarian hyperstimulation in mosaic Turner syndrome: another fertility preservation option in a dedicated UK clinic","volume":"117","author":"El-Shawarby","year":"2010","journal-title":"BJOG"},{"key":"2023090508450996800_dead135-B16","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1186\/s13023-022-02423-5","article-title":"Turner syndrome: French National Diagnosis and Care Protocol (NDCP; National Diagnosis and Care Protocol)","volume":"17","author":"Fiot","year":"2022","journal-title":"Orphanet J Rare Dis"},{"key":"2023090508450996800_dead135-B17","doi-asserted-by":"crossref","first-page":"1160258","DOI":"10.3389\/fendo.2023.1160258","article-title":"Ovarian dysfunction in women with Turner syndrome","volume":"14","author":"Fukami","year":"2023","journal-title":"Front Endocrinol (Lausanne)"},{"key":"2023090508450996800_dead135-B18","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1016\/j.fertnstert.2020.04.003","article-title":"Preimplantation genetic testing for aneuploidy in patients with partial X monosomy using their own oocytes: is this a suitable indication?","volume":"114","author":"Giles","year":"2020","journal-title":"Fertil Steril"},{"key":"2023090508450996800_dead135-B19","doi-asserted-by":"crossref","first-page":"e12471","DOI":"10.1002\/rmb2.12471","article-title":"Impact of abnormal karyotype on reproductive outcome in premature ovarian insufficiency","volume":"21","author":"Grin","year":"2022","journal-title":"Reprod Med Biol"},{"key":"2023090508450996800_dead135-B20","doi-asserted-by":"crossref","first-page":"1466","DOI":"10.1126\/science.aav7321","article-title":"Chromosome errors in human eggs shape natural fertility over reproductive life span","volume":"365","author":"Gruhn","year":"2019","journal-title":"Science"},{"key":"2023090508450996800_dead135-B21","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/j.fertnstert.2015.11.042","article-title":"Fertility preservation in Turner syndrome","volume":"105","author":"Grynberg","year":"2016","journal-title":"Fertil Steril"},{"key":"2023090508450996800_dead135-B22","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1007\/s00439-014-1420-x","article-title":"Turner syndrome revisited: review of new data supports the hypothesis that all viable 45,X cases are cryptic mosaics with a rescue cell line, implying an origin by mitotic loss","volume":"133","author":"Hook","year":"2014","journal-title":"Hum Genet"},{"key":"2023090508450996800_dead135-B23","doi-asserted-by":"crossref","first-page":"336","DOI":"10.1093\/humrep\/dem307","article-title":"Cryopreservation of ovarian tissue and in vitro matured oocytes in a female with mosaic Turner syndrome: case report","volume":"23","author":"Huang","year":"2008","journal-title":"Hum Reprod"},{"key":"2023090508450996800_dead135-B24","doi-asserted-by":"crossref","first-page":"1144","DOI":"10.1080\/09513590.2020.1822805","article-title":"DuoStim: a new option for fertility preservation for a woman with Turner syndrome","volume":"36","author":"Ito","year":"2020","journal-title":"Gynecol Endocrinol"},{"key":"2023090508450996800_dead135-B25","doi-asserted-by":"crossref","first-page":"hoz016","DOI":"10.1093\/hropen\/hoz016","article-title":"Time to consider ovarian tissue cryopreservation for girls with Turner's syndrome: an opinion paper","volume":"2019","author":"Jeve","year":"2019","journal-title":"Hum Reprod Open"},{"key":"2023090508450996800_dead135-B26","doi-asserted-by":"crossref","first-page":"601752","DOI":"10.3389\/fendo.2021.601752","article-title":"Ovarian reserve markers in premature ovarian insufficiency: within different clinical stages and different etiologies","volume":"12","author":"Jiao","year":"2021","journal-title":"Front Endocrinol (Lausanne)"},{"key":"2023090508450996800_dead135-B2700","article-title":"Oocyte cryopreservation in a woman with mosaic Turner syndrome: a case report","volume":"53","year":"2008","journal-title":"J Reprod Med"},{"key":"2023090508450996800_dead135-B27","doi-asserted-by":"crossref","first-page":"1594","DOI":"10.1016\/j.fertnstert.2004.06.042","article-title":"Mechanism of recurrent spontaneous abortions in women with mosaicism of X-chromosome aneuploidies","volume":"82","author":"Kuo","year":"2004","journal-title":"Fertil Steril"},{"key":"2023090508450996800_dead135-B28","doi-asserted-by":"crossref","first-page":"759","DOI":"10.1007\/s10815-021-02067-7","article-title":"Fertility preservation for genetic diseases leading to premature ovarian insufficiency (POI)","volume":"38","author":"La Marca","year":"2021","journal-title":"J Assist Reprod Genet"},{"key":"2023090508450996800_dead135-B2800","article-title":"Feasibility of fertility preservation in young females with Turner syndrome","volume":"18","year":"2009","journal-title":"Reprod Biomed Online"},{"key":"2023090508450996800_dead135-B29","doi-asserted-by":"crossref","first-page":"656","DOI":"10.1111\/j.1471-0528.1991.tb13451.x","article-title":"The variation of endometrial response to a standard hormone replacement therapy in women with premature ovarian failure. An ultrasonographic and histological study","volume":"98","author":"Li","year":"1991","journal-title":"Br J Obstet Gynaecol"},{"key":"2023090508450996800_dead135-B30","doi-asserted-by":"crossref","first-page":"1247","DOI":"10.1007\/s10815-021-02127-y","article-title":"Reproductive outcomes after preimplantation genetic testing in mosaic Turner syndrome: a retrospective cohort study of 100 cycles","volume":"38","author":"Liao","year":"2021","journal-title":"J Assist Reprod Genet"},{"key":"2023090508450996800_dead135-B31","doi-asserted-by":"crossref","first-page":"e1","DOI":"10.1016\/j.jclinepi.2009.06.006","article-title":"The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate health care interventions: explanation and elaboration","volume":"62","author":"Liberati","year":"2009","journal-title":"J Clin Epidemiol"},{"key":"2023090508450996800_dead135-B32","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1111\/aogs.13562","article-title":"The psychological importance of fertility preservation counseling and support for cancer patients","volume":"98","author":"Logan","year":"2019","journal-title":"Acta Obstet Gynecol Scand"},{"key":"2023090508450996800_dead135-B33","doi-asserted-by":"crossref","first-page":"2992","DOI":"10.1093\/humrep\/deab210","article-title":"Accelerated loss of oogonia and impaired folliculogenesis in females with Turner syndrome start during early fetal development","volume":"36","author":"Lundgaard Riis","year":"2021","journal-title":"Hum Reprod"},{"key":"2023090508450996800_dead135-B3400","article-title":"The use of oocyte cryopreservation for fertility preservation in patients with sex chromosome disorders: a case series describing outcomes","volume":"39","year":"2022","journal-title":"J Assist Reprod Genet"},{"key":"2023090508450996800_dead135-B34","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1093\/molehr\/gag031","article-title":"Accelerated germ cell apoptosis in sex chromosome aneuploid fetal human gonads","volume":"9","author":"Modi","year":"2003","journal-title":"Mol Hum Reprod"},{"key":"2023090508450996800_dead135-B35","doi-asserted-by":"crossref","first-page":"1280","DOI":"10.1016\/j.fertnstert.2020.11.006","article-title":"Why are some patients with 45,X Turner syndrome fertile? A young girl with classical 45,X Turner syndrome and a cryptic mosaicism in the ovary","volume":"115","author":"Nadesapillai","year":"2021","journal-title":"Fertil Steril"},{"key":"2023090508450996800_dead135-B3600","article-title":"Oocyte cryopreservation for fertility preservation in postpubertal female children at risk for premature ovarian failure due to accelerated follicle loss in Turner syndrome or cancer treatments","volume":"27","year":"2014","journal-title":"J Pediatr Adolesc Gynecol"},{"key":"2023090508450996800_dead135-B36","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1016\/j.jpag.2015.10.011","article-title":"Fertility preservation in women with Turner syndrome: a comprehensive review and practical guidelines","volume":"29","author":"Oktay","year":"2016","journal-title":"J Pediatr Adolesc Gynecol"},{"key":"2023090508450996800_dead135-B37","doi-asserted-by":"crossref","first-page":"753.e15-9","DOI":"10.1016\/j.fertnstert.2010.01.044","article-title":"Fertility preservation by ovarian stimulation and oocyte cryopreservation in a 14-year-old adolescent with Turner syndrome mosaicism and impending premature ovarian failure","volume":"94","author":"Oktay","year":"2010","journal-title":"Fertil Steril"},{"key":"2023090508450996800_dead135-B38","doi-asserted-by":"crossref","first-page":"1686","DOI":"10.1093\/humrep\/dez135","article-title":"Ovarian follicles of young patients with Turner's syndrome contain normal oocytes but monosomic 45,X granulosa cells","volume":"34","author":"Peek","year":"2019","journal-title":"Hum Reprod"},{"key":"2023090508450996800_dead135-B39","doi-asserted-by":"crossref","first-page":"1675","DOI":"10.1007\/s10815-020-01809-3","article-title":"Are ovarian response and pregnancy rates similar in selected FMR1 premutated and mutated patients undergoing preimplantation genetic testing?","volume":"37","author":"Ranisavljevic","year":"2020","journal-title":"J Assist Reprod Genet"},{"key":"2023090508450996800_dead135-B40","doi-asserted-by":"crossref","first-page":"1012","DOI":"10.1016\/j.fertnstert.2013.12.039","article-title":"Value of antimullerian hormone as a prognostic indicator of in vitro fertilization outcome","volume":"101","author":"Reichman","year":"2014","journal-title":"Fertil Steril"},{"key":"2023090508450996800_dead135-B41","doi-asserted-by":"crossref","first-page":"883","DOI":"10.1093\/oxfordjournals.humrep.a137754","article-title":"Turner's syndrome patients lack tight junctions between uterine epithelial cells","volume":"7","author":"Rogers","year":"1992","journal-title":"Hum Reprod"},{"key":"2023090508450996800_dead135-B42","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1159\/000098184","article-title":"X chromosome loss and ageing","volume":"116","author":"Russell","year":"2007","journal-title":"Cytogenet Genome Res"},{"key":"2023090508450996800_dead135-B43","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1186\/s43043-021-00071-6","article-title":"FSH versus AMH: age-related relevance to ICSI results","volume":"26","author":"Salama","year":"2021","journal-title":"Middle East Fertil Soc J"},{"key":"2023090508450996800_dead135-B44","doi-asserted-by":"crossref","first-page":"1061","DOI":"10.1093\/humrep\/deaa007","article-title":"International consensus: ovarian tissue cryopreservation in young Turner syndrome patients: outcomes of an ethical Delphi study including 55 experts from 16 different countries","volume":"35","author":"Schleedoorn","year":"2020","journal-title":"Hum Reprod"},{"key":"2023090508450996800_dead135-B45","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1007\/s10815-022-02420-4","article-title":"First live birth after fertility preservation using vitrification of oocytes in a woman with mosaic Turner syndrome","volume":"39","author":"Strypstein","year":"2022","journal-title":"J Assist Reprod Genet"},{"key":"2023090508450996800_dead135-B46","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1002\/ajmg.a.30911","article-title":"Turner syndrome: four challenges across the lifespan","volume":"139A","author":"Sutton","year":"2005","journal-title":"Am J Med Genet A"},{"key":"2023090508450996800_dead135-B47","doi-asserted-by":"crossref","first-page":"1227","DOI":"10.1056\/NEJMra030360","article-title":"Turner's syndrome","volume":"351","author":"Sybert","year":"2004","journal-title":"N Engl J Med"},{"key":"2023090508450996800_dead135-B48","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1016\/j.fertnstert.2018.11.010","article-title":"Outcome of ovarian stimulation for oocyte cryopreservation in women with Turner syndrome","volume":"111","author":"Talaulikar","year":"2019","journal-title":"Fertil Steril"},{"key":"2023090508450996800_dead135-B49","doi-asserted-by":"crossref","first-page":"83","DOI":"10.3109\/09513599809024955","article-title":"Pregnancy in patients with Turner's syndrome: six new cases and review of literature","volume":"12","author":"Tarani","year":"1998","journal-title":"Gynecol Endocrinol"},{"key":"2023090508450996800_dead135-B50","doi-asserted-by":"crossref","first-page":"646","DOI":"10.1111\/cen.14076","article-title":"Fertility preservation in Turner syndrome: karyotype does not predict ovarian response to stimulation","volume":"91","author":"Vergier","year":"2019","journal-title":"Clin Endocrinol (Oxf)"},{"key":"2023090508450996800_dead135-B51","doi-asserted-by":"crossref","first-page":"702061","DOI":"10.3389\/fendo.2021.702061","article-title":"Evaluation of ovarian reserve tests and age in the prediction of poor ovarian response to controlled ovarian stimulation-a real-world data analysis of 89,002 patients","volume":"12","author":"Wang","year":"2021","journal-title":"Front Endocrinol (Lausanne)"},{"key":"2023090508450996800_dead135-B52","doi-asserted-by":"crossref","first-page":"1249","DOI":"10.1016\/S0015-0282(16)58350-2","article-title":"Patients with Turner's syndrome may have an inherent endometrial abnormality affecting receptivity in oocyte donation","volume":"65","author":"Yaron","year":"1996","journal-title":"Fertil Steril"}],"container-title":["Human Reproduction"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/humrep\/article-pdf\/38\/9\/1733\/51345416\/dead135.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/humrep\/article-pdf\/38\/9\/1733\/51345416\/dead135.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,9,5]],"date-time":"2023-09-05T04:49:18Z","timestamp":1693889358000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/humrep\/article\/38\/9\/1733\/7209865"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,6,28]]},"references-count":56,"journal-issue":{"issue":"9","published-online":{"date-parts":[[2023,6,28]]},"published-print":{"date-parts":[[2023,9,5]]}},"URL":"https:\/\/doi.org\/10.1093\/humrep\/dead135","relation":{},"ISSN":["0268-1161","1460-2350"],"issn-type":[{"value":"0268-1161","type":"print"},{"value":"1460-2350","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2023,9,1]]},"published":{"date-parts":[[2023,6,28]]}}}